Dyne Therapeutics
Price & Volume
Stats
See more52W Range | $11.92-$27.30 |
Market Cap | $2.9B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.26 |
News
See moreYahoo Finance • 10 days ago
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 18 days ago
Dyne Therapeutics Myotonic Dystrophy Approach Remains Differentiated, RBC Says
Yahoo Finance • 18 days ago
Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
Yahoo Finance • 20 days ago
Novartis drops 13% on trial failure, dragging Dyne and Sarepta
About
CEO | Mr. John G. Cox M.B.A. |
CFO | Mr. Erick J. Lucera C.F.A., CPA |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 289 |